Risk of supply chain disruptions due to prolonged and worsening effects of the infectious disease
First written in FY2020. 3 of 8 entries say "Materialised", first in FY2022-Q2. Latest entry: FY2023.
The whole theme swung hardest in 2025: 5 of 16 companies on the "Worse" side.
19 other companies' latest entry also says "Mitigated".
- FY2023MitigatedAnnual report
「The risk of severe illness from COVID-19 has declined as vaccinations have become more widespread, and economic activity is returning to normal. However, if the containment of infections is delayed or the impact becomes prolonged, stagnation in domestic and overseas supply chains and a downturn in economic conditions could affect our Group's performance.」
The contraction in economic activity caused by the infection is said to be moving toward normalization, partially easing the previously identified supply chain disruption risk, although the possibility of an impact if the situation is prolonged remains. - FY2023-Q2WorsenedAnnual report
「During the second quarter of the current consolidated fiscal year, the impact of prolonged TEPRA stockouts due to the semiconductor shortage continued. However, supported by sales from ライフオンプロダクツ㈱, which became a consolidated subsidiary in November 2021, revenue was ¥18,582.31 million, up 14.0% year on year.」
The impact of TEPRA stockouts caused by the semiconductor shortage continued into the current quarter. - FY2023-Q1WorsenedAnnual report
「During the first quarter of the current consolidated fiscal year, the impact of prolonged TEPRA stockouts due to the semiconductor shortage led to a substantial decline in sales. However, supported by sales from ライフオンプロダクツ㈱, which became a consolidated subsidiary in November 2021, revenue was ¥8,670.58 million, up 10.0% year on year.」
TEPRA stockouts and lower sales caused by the semiconductor shortage persisted, and the impact of supply chain disruption continued in the current quarter. - FY2022MaterialisedAnnual report
「The impact of prolonged stockouts of TEPRA products due to the semiconductor shortage and file stockouts caused by lockdowns in production countries resulted in a substantial decline in sales, although」
Lockdowns in response to the infection and supply disruptions caused by the semiconductor shortage emerged throughout the fiscal year as stockouts and lower sales. - FY2022-Q3MaterialisedAnnual report
「During the first 3 quarters of the current consolidated fiscal year, revenue benefited from sales at ライフオンプロダクツ㈱, beginning with the current third quarter consolidated accounting period. However, the impact of stockouts of files and other products due to lockdowns at production plants in Southeast Asia, as well as stockouts of TEPRA products due to the semiconductor shortage, resulted in revenue of ¥26,345.69 million, down 2.1% year on year.」
The suspension of supply from factories in Southeast Asia due to lockdowns and the semiconductor shortage materialized as stockouts of files and TEPRA products and lower revenue. - FY2022-Q2MaterialisedAnnual report
「At ぼん家具, operations at factories in Southeast Asia were suspended because of lockdowns, causing difficulties in dealing with stockouts.」
Lockdowns implemented in response to the infection led to the suspension of operations at factories in Southeast Asia and difficulties dealing with stockouts, and the supply chain disruption risk materialized. - FY2021-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The company stated that there had been no material changes to the risk of supply chain disruption resulting from a prolonged or worsening impact of the infection. - FY2020First statedAnnual report
「However, if the impact of the spread of COVID-19 becomes prolonged or more severe, stagnation in domestic and overseas supply chains and a downturn in economic conditions could affect our Group's performance.」
The company organized the prolonged or worsening impact of the infection as a performance risk through supply chain disruption and a downturn in economic conditions.